Cessation rate of anti-osteoporosis treatments and risk factors in Spanish primary care settings: a population-based cohort analysis by Martín-Merino, E, Huerta-Álvarez, C, Prieto-Alhambra, D, Montero-Corominas, D

Secular trends of use of anti-osteoporosis treatments in Spain: a population-based cohort study including over 1.5 million people and more than 12 years of follow-up by Martín-Merino, E, Huerta-Álvarez, C, Prieto-Alhambra, D, Álvarez-Gutiérrez, A, Montero-Corominas, C

Incidence and persistence to antiosteoporosis treatments in Spanish primary care settings: a population-based cohort study by Martin-Merino, E, Alvarez-Gutierrez, A, Huerta-Alvarez, C, Prieto-Alhambra, D, Montero-Corominas, D

The impact of different strategies to handle missing data on both precision and bias in a drug safety study: a multidatabase multinational population-based cohort study by Martin-Merino, E, Calderón-Larrañaga, A, Hawley, S, Poblador-Plou, B, Llorente, A, Petersen, I, Prieto-Alhambra, D

The impact of different strategies to handle missing data on both precision and bias in a drug safety study: a multidatabase multinational population-based cohort study by Martín-Merino E, Calderón-Larrañaga A, Hawley S, Poblador-Plou B, Llorente-García A, Petersen I, Prieto-Alhambra D

Get full text

Risk of venous thromboembolism amongst users of different antiosteoporosis drugs: a multinational population-based cohort study by Martin-Merino, E, Petersen, I, Hawley, S, Alvarez-Gutierrez, A, Delmestri, A, Llorente-Garcia, A, Javaid, K, Van Staa, T, Judge, A, Cooper, C, Prieto-Alhambra, D

Risk of venous thromboembolism amongst users of different anti-osteoporosis drugs: a multinational population-based cohort study by Martin-Merino, E, Petersen, I, Hawley, S, Alvarez-Gutierrez, A, Delmestri, A, Llorente-Garcia, A, Javaid, K, van Staa, T, Judge, A, Cooper, C, Prieto-Alhambra, D

Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK by Martín-Merino, E, Petersen, I, Hawley, S, Álvarez-Gutierrez, A, Khalid, S, Llorente-Garcia, A, Delmestri, A, Javaid, M, Van Staa, T, Judge, A, Cooper, C, Prieto-Alhambra, D

ADVANCE system testing: estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data by Dodd, C, de Ridder, M, Weibel, D, Mahaux, O, Haguinet, F, de Smedt, T, de Lusignan, S, McGee, C, Duarte-Salles, T, Emborg, H-D, Huerta, C, Martín-Merino, E, Picelli, G, Berencsi, K, Danieli, G, Sturkenboom, M

Incidence rates of autoimmune diseases in European healthcare databases: a contribution of the ADVANCE project by Willame, C, Dodd, C, van der Aa, L, Picelli, G, Emborg, H-D, Kahlert, J, Gini, R, Huerta, C, Martín-Merino, E, McGee, C, de Lusignan, S, Roberto, G, Villa, M, Weibel, D, Titievsky, L, Sturkenboom, MCJM

ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations by Sturkenboom, M, Braeye, T, van der Aa, L, Danieli, G, Dodd, C, Duarte-Salles, T, Emborg, H-D, Gheorghe, M, Gini, R, Huerta, C, Kahlert, J, de Lusignan, S, Martín-Merino, E, McGee, C, Picelli, G, Roberto, G, Tramontan, L, Villa, M, Weibel, D, Titievsky, L

Advance system testing: Vaccine benefit studies using multi-country electronic health data: the example of pertussis vaccination by Tin Tin Htar, M, De Ridder, M, Braeye, T, Correa, A, McGee, C, De Lusignan, S, Duarte-Salles, T, Huerta-Alvares, C, Martín-Merino, E, Tramontan, L, Danieli, G, Picelli, G, Van Der Maas, N, Berencsi, K, Arnheim-Dahlström, L, Heininger, U, Emborg, H, Weibel, D, Bollaerts, K, Sturkenboom, M